Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The Safety and Efficacy of IMPT or IMRT for Breast Cancer: A Prospective Observational Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06826885
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:51.743227+00:00
Published At
2025-02-14T00:00:00+00:00
Record Updated At
2025-02-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Breast Cancer", "Proton Therapy", "Intensity Modulated Radiation Therapy", "Efficacy and Safety", "Radiotherapy, Adjuvant"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-14"
protocolSection.identificationModule.nctId
"NCT06826885"
protocolSection.identificationModule.officialTitle
"The Safety and Efficacy of IMPT or IMRT for Breast Cancer: A Prospective Observational Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • Proton Therapy (protocolSection.conditionsModule.conditions)
  • Intensity Modulated Radiation Therapy (protocolSection.conditionsModule.conditions)
  • Efficacy and Safety (protocolSection.conditionsModule.conditions)
  • Radiotherapy, Adjuvant (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.